Literature DB >> 1374064

The role of radiation therapy in the treatment of brain metastases.

L R Coia1.   

Abstract

Whole brain irradiation is the most effective means for treating the patient with brain metastases with symptom relief occurring in 70 to 90% of patients. However, 25-50% of patients with brain metastases will die due to eventual failure in the brain and therefore entry of patients into investigative trials is essential for continued progress in the management of this problem. For the patient who is not part of an investigative trial, short courses of radiation of 20 Gy in 1 week or 30 Gy in 2 weeks are generally as effective as more prolonged courses and even shorter courses of treatment could be considered, particularly for the patient with an estimated survival of only 5-6 weeks. The importance of the treatment of brain metastases on the practice of radiation oncology is significant and comparable to other major cancers treated with radiation. It is critical that radiation oncologists can apply this treatment modality in a cost effective manner with careful consideration for the patients' quality of life.

Entities:  

Mesh:

Year:  1992        PMID: 1374064     DOI: 10.1016/0360-3016(92)90567-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 2.  Brain metastases in oncogene-driven non-small cell lung cancer.

Authors:  Makoto Nishino; Kenzo Soejima; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2019-11

3.  A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Authors:  L E Abrey; J D Olson; J J Raizer; M Mack; A Rodavitch; D Y Boutros; M G Malkin
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

4.  Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing.

Authors:  Marianna Trignani; Domenico Genovesi; Annamaria Vinciguerra; Angelo Di Pilla; Antonietta Augurio; Monica Di Tommaso; Giampiero Ausili Cèfaro; Marta Di Nicola
Journal:  Radiol Med       Date:  2014-07-18       Impact factor: 3.469

5.  Radiotherapy response of cerebral metastases quantified by serial MR imaging.

Authors:  E J Zijlstra; M J Taphoorn; F Barkhof; F G Hoogenraad; J J Heimans; J Valk
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Ten years disease-free survival after solitary brain metastasis from breast cancer.

Authors:  C Nieder; K Walter; U Nestle; K Schnabel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.

Authors:  Xiao-Xiao Dinglin; Yan Huang; Hui Liu; Yin-Duo Zeng; Xue Hou; Li-Kun Chen
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

8.  Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.

Authors:  Doo-Sik Kong; Jung-Il Lee; Do-Hyun Nam; Kwan Park; Jong Hyun Kim; Jhin Gook Kim; Jun-O Park; Keunchil Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 9.  Radiotherapy for metastatic brain tumors.

Authors:  Yuta Shibamoto; Chikao Sugie; Hiromitsu Iwata
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

10.  Clinical analysis of novalis stereotactic radiosurgery for brain metastases.

Authors:  Hae-Won Gu; Moon-Jun Sohn; Dong-Joon Lee; Hye Ran Lee; Chae-Heuck Lee; C Jin Whang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.